These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7525957

  • 1. Localization of endothelin-1 and its binding sites in scleroderma skin.
    Vancheeswaran R, Azam A, Black C, Dashwood MR.
    J Rheumatol; 1994 Jul; 21(7):1268-76. PubMed ID: 7525957
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [Abstract] [Full Text] [Related]

  • 3. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Vancheeswaran R, Magoulas T, Efrat G, Wheeler-Jones C, Olsen I, Penny R, Black CM.
    J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
    [Abstract] [Full Text] [Related]

  • 4. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
    Sulli A, Soldano S, Pizzorni C, Montagna P, Secchi ME, Villaggio B, Seriolo B, Brizzolara R, Cutolo M.
    J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
    [Abstract] [Full Text] [Related]

  • 5. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
    Young-Min SA, Beeton C, Laughton R, Plumpton T, Bartram S, Murphy G, Black C, Cawston TE.
    Ann Rheum Dis; 2001 Sep; 60(9):846-51. PubMed ID: 11502611
    [Abstract] [Full Text] [Related]

  • 6. Characterization of endothelin-binding sites in human skin and their regulation in primary Raynaud's phenomenon and systemic sclerosis.
    Knock GA, Terenghi G, Bunker CB, Bull HA, Dowd PM, Polak JM.
    J Invest Dermatol; 1993 Jul; 101(1):73-8. PubMed ID: 8331298
    [Abstract] [Full Text] [Related]

  • 7. Impaired growth response to endothelin-1 in scleroderma fibroblasts.
    Kikuchi K, Kadono T, Sato S, Tamaki K, Takehara K.
    Biochem Biophys Res Commun; 1995 Feb 15; 207(2):829-38. PubMed ID: 7864878
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M, Guiducci S, Romano E, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M.
    Ann Rheum Dis; 2012 Jun 15; 71(6):1064-72. PubMed ID: 22258486
    [Abstract] [Full Text] [Related]

  • 10. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P, Medsger TA, Morel PA.
    Arthritis Rheum; 2009 Apr 15; 60(4):1119-28. PubMed ID: 19333920
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis.
    Lawrence A, Khanna D, Misra R, Aggarwal A.
    Dermatol Online J; 2006 Jan 27; 12(1):2. PubMed ID: 16638370
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased pigmentation in scleroderma.
    Pope JE, Shum DT, Gottschalk R, Stevens A, McManus R.
    J Rheumatol; 1996 Nov 27; 23(11):1912-6. PubMed ID: 8923365
    [Abstract] [Full Text] [Related]

  • 14. Noninvasive measurement of skin autofluorescence is increased in patients with systemic sclerosis: an indicator of increased advanced glycation endproducts?
    Murray AK, Moore TL, Manning JB, Griffiths CE, Herrick AL.
    J Rheumatol; 2012 Aug 27; 39(8):1654-8. PubMed ID: 22753661
    [Abstract] [Full Text] [Related]

  • 15. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis.
    Sawaya HH, Jimenez SA, Artlett CM.
    Rheumatology (Oxford); 2004 Aug 27; 43(8):965-8. PubMed ID: 15199216
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
    Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S.
    J Rheumatol; 2006 Feb 27; 33(2):275-84. PubMed ID: 16465658
    [Abstract] [Full Text] [Related]

  • 17. HLA-G expression in the skin of patients with systemic sclerosis.
    Wastowski IJ, Sampaio-Barros PD, Amstalden EM, Palomino GM, Marques-Neto JF, Crispim JC, Biral AC, Rassi DM, Carosella ED, Moreau P, Donadi EA.
    J Rheumatol; 2009 Jun 27; 36(6):1230-4. PubMed ID: 19369464
    [Abstract] [Full Text] [Related]

  • 18. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M, Vidali M, De Andrea M, Azzimonti B, Airò P, D'Ambrosio R, Riboldi P, Meroni PL, Albano E, Shoenfeld Y, Gariglio M, Landolfo S.
    Arthritis Rheum; 2006 Dec 27; 54(12):3939-44. PubMed ID: 17133607
    [Abstract] [Full Text] [Related]

  • 19. [Characteristic of the endogenous peptides--endothelins and their role in the connective tissue fibrosis].
    Garncarczyk A, Jurzak M, Gojniczek K.
    Wiad Lek; 2008 Dec 27; 61(4-6):126-34. PubMed ID: 18939363
    [Abstract] [Full Text] [Related]

  • 20. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.
    Santiago B, Galindo M, Rivero M, Pablos JL.
    Arthritis Rheum; 2001 Jul 27; 44(7):1667-76. PubMed ID: 11465719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.